Robert Wasserman
Stock Analyst at Benchmark Co.
(4.34)
# 1,326
Out of 5,076 analysts
220
Total ratings
46.8%
Success rate
11.7%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLV: KMDA Kamada Ltd. | Reiterated: Buy | ILA 4,642 | ILA 2,397 | +93.66% | 6 | Sep 18, 2026 | |
| LGND Ligand Pharmaceuticals | Reiterated: Buy | $220 → $335 | $303.53 | +10.37% | 20 | Jul 16, 2026 | |
| RGEN Repligen | Upgraded: Buy | $185 | $176.93 | +4.56% | 11 | Jul 7, 2026 | |
| PRLB Proto Labs | Reiterated: Buy | $91 | $85.61 | +6.30% | 16 | Jul 6, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | n/a | $72.55 | - | 18 | Jun 30, 2026 | |
| ITGR Integer Holdings | Upgraded: Buy | $140 → $95 | $126.54 | -24.92% | 18 | Feb 20, 2026 | |
| HALO Halozyme Therapeutics | Reiterated: Buy | $90 | $125.63 | -28.36% | 22 | Feb 19, 2026 | |
| CDXS Codexis | Reiterated: Hold | n/a | $1.28 | - | 16 | Nov 14, 2025 | |
| OABI OmniAb | Reiterated: Buy | $6 → $4 | $4.66 | -14.16% | 11 | Nov 6, 2025 | |
| INTS Intensity Therapeutics | Reiterated: Buy | $38 | $3.25 | +1,053.85% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.82 | n/a | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $3.53 | n/a | 8 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $6.23 | n/a | 20 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.16 | n/a | 8 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $2.09 | n/a | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $673.82 | n/a | 7 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $230.50 | n/a | 5 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.72 | n/a | 4 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $80 | $1.81 | n/a | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.93 | n/a | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.64 | n/a | 3 | Jan 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $0.1819 | n/a | 1 | Jan 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $0.3221 | n/a | 1 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.4 | $1.93 | n/a | 2 | Jan 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.25 | $0.6825 | n/a | 1 | Nov 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $6.33 | n/a | 1 | Mar 12, 2013 |
Kamada Ltd.
Sep 18, 2026
Reiterated: Buy
Price Target: ILA 4,642
Current: ILA 2,397
Upside: +93.66%
Ligand Pharmaceuticals
Jul 16, 2026
Reiterated: Buy
Price Target: $220 → $335
Current: $303.53
Upside: +10.37%
Repligen
Jul 7, 2026
Upgraded: Buy
Price Target: $185
Current: $176.93
Upside: +4.56%
Proto Labs
Jul 6, 2026
Reiterated: Buy
Price Target: $91
Current: $85.61
Upside: +6.30%
Bio-Techne
Jun 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $72.55
Upside: -
Integer Holdings
Feb 20, 2026
Upgraded: Buy
Price Target: $140 → $95
Current: $126.54
Upside: -24.92%
Halozyme Therapeutics
Feb 19, 2026
Reiterated: Buy
Price Target: $90
Current: $125.63
Upside: -28.36%
Codexis
Nov 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.28
Upside: -
OmniAb
Nov 6, 2025
Reiterated: Buy
Price Target: $6 → $4
Current: $4.66
Upside: -14.16%
Intensity Therapeutics
Oct 31, 2025
Reiterated: Buy
Price Target: $38
Current: $3.25
Upside: +1,053.85%
Aug 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $11.82
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $5
Current: $3.53
Upside: n/a
Aug 8, 2025
Reiterated: Buy
Price Target: $12
Current: $6.23
Upside: n/a
Jul 31, 2025
Reiterated: Buy
Price Target: $3
Current: $1.16
Upside: n/a
Feb 3, 2025
Downgraded: Hold
Price Target: $4
Current: $2.09
Upside: n/a
Oct 26, 2023
Reiterated: Hold
Price Target: n/a
Current: $673.82
Upside: n/a
Oct 25, 2023
Reiterated: Hold
Price Target: n/a
Current: $230.50
Upside: n/a
Sep 15, 2023
Reiterated: Hold
Price Target: n/a
Current: $4.72
Upside: n/a
Apr 4, 2023
Reiterated: Buy
Price Target: $9 → $80
Current: $1.81
Upside: n/a
Feb 24, 2021
Reiterated: Buy
Price Target: $9
Current: $1.93
Upside: n/a
Jan 24, 2020
Rated: Hold
Price Target: n/a
Current: $1.64
Upside: n/a
Jan 9, 2019
Initiated Coverage: Buy
Price Target: $11
Current: $0.1819
Upside: n/a
Aug 28, 2018
Initiated Coverage: Buy
Price Target: $46
Current: $0.3221
Upside: n/a
Jan 29, 2018
Initiated Coverage: Buy
Price Target: $2.4
Current: $1.93
Upside: n/a
Nov 7, 2013
Initiated Coverage: Buy
Price Target: $5.25
Current: $0.6825
Upside: n/a
Mar 12, 2013
Reiterated: Buy
Price Target: $6
Current: $6.33
Upside: n/a